STN:NYSEStantec Inc Analysis
Data as of 2026-08-02 - not real-time
$70.49
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Stantec Inc. (STN) is trading at $70.49, well below its DCF-derived fair value of $102.43, suggesting a sizable discount. The stock’s trailing P/E of 23 is comfortably under the industry average of 31, while the forward P/E of 14.4 signals improving earnings expectations. Revenue is expanding at a solid 9% YoY with a healthy gross margin of 54% and operating margin above 10%, underscoring robust operational performance. Cash flow remains strong, with operating cash flow of $760 M and free cash flow of $739 M, supporting the modest 21% payout ratio and a dividend yield near 1%. However, the balance sheet carries a net debt of $2.23 B (debt‑to‑equity 77%), which warrants monitoring. Technicals show a mixed picture: price sits above the 20‑day SMA but below the 50‑day SMA, the MACD histogram is positive and the signal line is bullish, yet the 30‑day volatility is high at ~30% and the long‑term trend remains bearish. Recent news highlights a strategic joint‑venture win in Melbourne’s water infrastructure and a forthcoming Q2 earnings release, both of which could catalyze short‑term upside. Investor sentiment is buoyant, reflected by an “Extreme Greed” reading of 92.9 on the Fear & Greed Index. Overall, the combination of valuation discount, solid fundamentals, and positive project pipeline positions STN as an attractive entry point, provided investors are comfortable with the inherent cyclical and leverage risks.
While the stock’s upside potential appears compelling, the elevated volatility and debt levels suggest a measured approach, with a focus on upcoming earnings and cash‑flow trends to confirm the upside narrative.
While the stock’s upside potential appears compelling, the elevated volatility and debt levels suggest a measured approach, with a focus on upcoming earnings and cash‑flow trends to confirm the upside narrative.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term support and mixed technical signals
- Upcoming Q2 earnings could clarify momentum
- High 30‑day volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount to DCF fair value
- Strong cash flow supporting dividend and debt service
- Strategic project win in Australia expanding growth pipeline
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained revenue growth and improving margins
- Undervalued relative to industry peers with attractive forward P/E
- Continued dividend sustainability and solid ROE
Key Metrics & Analysis
Financial Health
Revenue Growth9.10%
Profit Margin7.39%
P/E Ratio23.0
ROE15.28%
ROA6.63%
Debt/Equity76.67
P/B Ratio3.4
Op. Cash Flow$759.9M
Free Cash Flow$739.2M
Industry P/E30.9
Technical Analysis
TrendBearish
RSI51.4
Support$66.26
Resistance$72.33
MA 20$69.34
MA 50$71.08
MA 200$89.28
MACDBullish
VolumeStable
Fear & Greed Index92.88
Valuation
Fair Value$102.43
GradeUndervalued
TypeBlend
Dividend Yield0.95%
Risk Assessment
Beta0.82
Volatility29.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.